Little Green Pharma Ltd (ASX: LGP) - Share Price
Current share price for LGP : $0.061 0.002 (3.17%)+
Little Green Pharma Ltd (LGP), an ASX-listed company, is a Company engaged in the cultivation of medicinal cannabis, procurement of raw materials and production of medicinal cannabis medicines, supply of medicinal cannabis products into Australia and Europe; supply of medicinal cannabis products for observational and clinical studies and research and development of new medicinal cannabis products; and development of a psychedelics business including sponsoring a clinical trial into the treatment of refractory depression with psilocybin assisted therapy and more.
LGP General Information +
| ASX Code | LGP |
| Website | http://littlegreenpharma.com |
| Industry/Sector | Pharmaceuticals |
| Market Cap ($M) | 50 |
| LGP Share Price | $0.061 |
| Day High | $0.063 |
| Day Low | $0.060 |
| Last Close | $0.063 |
| LGP Share Price Movement | $0.00 ( 3.17% ) |
Prices as at 16:41, 30 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Little Green Pharma Ltd (LGP) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Little Green Pharma Ltd (LGP) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Little Green Pharma Ltd (LGP) price-sensitive announcements
LGP - Implementation of Merger between LGP and Cannatrek
Little Green Pharma Ltd (LGP) successfully implemented its merger with Cannatrek Ltd, acqu
Little Green Pharma Ltd (LGP)
1 Jun 2026 | 9:32 AM
1 Jun 2026 | 9:32 AM
LGP - Court Approves the Scheme and Scheme Becomes Effective
The Federal Court of Australia has approved the scheme of arrangement whereby Little Green
Little Green Pharma Ltd (LGP)
25 May 2026 | 5:03 PM
25 May 2026 | 5:03 PM
LGP - Appendix 4E and 2026 Annual Report
The 2026 Annual Report and Appendix 4E for Little Green Pharma Ltd details the company's f
Little Green Pharma Ltd (LGP)
21 May 2026 | 9:40 AM
21 May 2026 | 9:40 AM
LGP - Transaction Update and General Meeting Update
Little Green Pharma Ltd (LGP) announced an update regarding its proposed acquisition of Ca
Little Green Pharma Ltd (LGP)
11 May 2026 | 8:38 AM
11 May 2026 | 8:38 AM
Little Green Pharma Ltd (LGP) Recent ASX Announcements
LGP Financial Summary
| Year to Mar | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026A | -$1.49 | -$0.50 | -144.60% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2025A | $3.32 | $1.10 | -140.40% | 10.60 | 0.00 | 0.00% | 0.0% |
| 2024A | -$8.15 | -$2.70 | -20.50% | 0.00 | 0.00 | 0.00% | 0.0% |
LGP Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | ||
| Clarity Pharmaceuticals Ltd (CU6) | $677M | 0.3002 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Little Green Pharma Ltd (LGP) | $52M | -1.4455 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Neuren Pharmaceuticals Limited (NEU) | $1,547M | -0.7857 | 0.0743 | 1.2000 | 52.4280 | 48.8000 | 22.1818 | 0.00% | 0.00% | 0.00% |
LGP Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.56 | 0.00 | 0.23 | 0.00 |
| Market | 0.29 | 13.30 | 1.15 | 0.67 |
| Sector | 0.43 | 26.30 | 2.45 | 2.43 |
LGP Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Paul Long | Chief Executive Officer, Managing Director | 1 Mar 2025 |
| Mr Brent Dennison | Non-Executive Chairman | 1 Jun 2026 |
| Mr Michael David Lynch-Bell | Non-Executive Chairman, Non-Executive Director | 13 Nov 2018 |
| Mr Seth Yakatan | Non-Executive Director | 1 Jun 2026 |
| Mr Thomas Huppert | Non-Executive Director | 1 Jun 2026 |
Little Green Pharma Ltd (LGP) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 28 May 2026 | SOLOMON, Fleta | Sell | Direct Shares | 8,404 | $0.094 | $790.000 |
| 26 May 2026 | SOLOMON, Fleta | Sell | Direct Shares | 5,000 | $0.095 | $475.000 |
| 27 Sep 2023 | SOLOMON, Fleta | Issued | Direct Shares | 277,777 | $0.180 | $49,999.860 |
See all changes in directors' interest & trades for Little Green Pharma Ltd (LGP) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
LGP Management
| Name | Position |
|---|---|
| Paula Butler | Chief Financial Officer |
| Alistair Warren | Company Secretary |
LGP Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Little Green Pharma Ltd (LGP). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 59,962,402 (19.60%) | TIGA Trading Pty Ltd |
| 21,873,216 (7.15%) | Fleta Jennifer Solomon |
LGP Calendar of Events
| Date | Event |
|---|---|
| 20 May 2027 | Report (Annual) |
| 20 May 2027 | Report (Prelim) |
| 20 November 2026 | Report (Interim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
